BriefCase vs DynaMed Decisions

BriefCase offers a mobile app for both iOS and Android, enabling care teams to access suspected findings, image views, and secure chat functions from anywhere. This mobile accessibility, combined with seamless integration into existing PACS, RIS, and EHR systems, suggests a highly adaptable and user-friendly experience for clinicians on the go. DynaMed Decisions also has a mobile app and EHR integration, but its primary focus is on providing evidence-based information rather than real-time communication and workflow triage, making BriefCase's mobile capabilities more impactful for immediate usability in critical situations.

BriefCase is an FDA-cleared AI-powered solution specifically designed for triaging critical medical imaging findings, with numerous published studies demonstrating its accuracy and impact on reducing overlooked cases and improving turnaround times for time-sensitive conditions like intracranial hemorrhage and pulmonary embolism. While DynaMed Decisions provides valuable individualized clinical guidance, risk calculators, and patient decision aids, it explicitly states it 'does not use AI in any of its tooling' and relies on peer-reviewed predictive models, positioning it more as a comprehensive reference tool rather than an AI-driven diagnostic or triage aid.

DynaMed Decisions, or its related product DynaMed, offers more transparent pricing, with individual subscriptions starting at $399/year ($475/year with Dyna AI). Aidoc's BriefCase, on the other hand, uses an enterprise pricing model that starts at approximately $50,000 per site per year, making it a premium platform primarily suited for large hospitals and health systems. This significant cost difference makes DynaMed Decisions a more accessible and transparent option for a broader range of users and institutions.

Aidoc's BriefCase is designed for large hospitals and health systems, with over 500 global customers and robust integrations with PACS, RIS, and EHR systems. It boasts extensive compliance certifications including FDA clearance, HIPAA, SOC2, and GDPR, indicating a strong foundation for enterprise-level deployment and data security. DynaMed Decisions also offers EHR integration and HIPAA compliance, but its stated target size and customer count are not as extensively detailed, suggesting Aidoc has a more established presence and proven track record in large-scale enterprise environments.

BriefCase leverages FDA-cleared AI for critical finding detection and workflow prioritization in medical imaging, actively utilizing AI to streamline communication and improve response times for urgent cases. DynaMed Decisions, while offering advanced clinical decision support and patient engagement tools, explicitly states that it 'does not use AI in any of its tooling' and relies on predictive models published in peer-reviewed literature. This distinction gives BriefCase a clear edge in terms of innovative application of AI directly within clinical workflows. However, it is worth noting that EBSCO's related product, DynaMed, launched 'Dyna AI' in 2024, a generative AI layer for conversational answers.

Both tools offer comprehensive support. Aidoc provides extensive documentation through its clinical compendium and emphasizes transparency with model cards and analytics for customers to monitor AI performance. DynaMed Decisions offers 24/7 customer support via phone and email, along with detailed user guides and a strong emphasis on evidence-based methodology and editorial processes. Without more specific comparative data on the quality or breadth of support channels and documentation, it is difficult to definitively declare a winner.